摘要:
The invention provides SARS-2 spike protein designs and uses thereof. The invention relates, in general, to modified SARS-CoV-2 proteins, nucleic acids encoding these, methods of making recombinant proteins and nucleic acids, compositions comprising these and their use in vaccination regimens, and diagnostic assays.
摘要:
The invention provides mycobacterial plasmids expressing antigens and immunogenic compositions comprising these plasmids, methods for quality control of such compositions, and their use in immunization methods.
摘要:
The invention is directed to modified HIV-l envelopes, compositions comprising these modified envelopes, nucleic acids encoding these modified envelopes, compositions comprising these nucleic acids, and methods of using these modified HIV-l envelopes and/or these nucleic acids to induce immune responses.
摘要:
The present invention relates, in general, to antibody-dependent cellular cytoxicity (ADCC)-mediating antibodies, and, in particular, to ADCC-mediating antibodies (and fragments thereof) suitable for use, for example, in reducing the risk of HIV-1 infection in a subject. The invention further relates to compositions comprising such antibodies or antibody fragents.
摘要:
The invention is directed to multispecific molecules comprising an HIV-1 envelope targeting arm and an arm targeting an effector cell, compositions comprising these molecules and methods of use.
摘要:
The invention provides immunogenic compositions which comprise HIV-1 envelope trimers in and a liposome. In other aspects the invention provides method of using compositions HIV-1 envelope trimers to induce immune response in a subject. The invention further provides methods to make compositions which comprise HIV-1 envelope trimers and a liposome.
摘要:
Described herein are antibody reagents that bind therapeutic targets such as SARS-COV2 spike protein, as well as methods of using such antibody reagents.
摘要:
The invention is directed to coronavirus based immunogens, including immunogens comprising spike protein and or domains thereof, comprised in multimeric complexes. Provided are also methods of using these immunogens to induce immunogenic responses in a subject.